New research reveals Australia has the world's highest estimated prevalence of anorexia and bulimia, raising concerns about ...

Follow-up analysis shows a 36% lower death hazard than placebo and no new safety signals associated with long-term use.

Experts have welcomed plans to strengthen sunscreen testing and manufacturing standards but warn that better regulation alone ...

Listen to the delayed presentations, key diagnostic clues, testing options, prescribing pitfalls and practical tick-avoidance ...

You may know her for her time as AMA Queensland president, but this GP, practice owner, and mother has more than a few insights into practice under her belt.

A payroll tax exemption for Victorian GPs is within tasting distance, with the state heading to the polls in just four weeks’ time.

Listen to how low-carbohydrate, real food diets can be integrated with GLP-1 agonists in everyday general practice.

Five peak medical organisations are ‘urgently’ calling on the New South Wales premier to freeze further pharmacy prescribing expansions for managing chronic conditions, citing a lack of evidence.

New Australian research suggests disseminating evidence and clinical guidance regarding the use of doxycycline post-exposure prophylaxis has significantly reduced the rate of syphilis and chlamydia in ...

New phase 3 trial finds no significant benefit over placebo at three months or one year, despite measurable changes to the gut microbiota.

An Australian expert panel outlines how GPs can navigate prescribing and funding barriers for patients with type 2 diabetes ...

Health ministers from Victoria, South Australia, Tasmania, Western Australia, and the ACT are calling on federal health ...